Aspergillosis, the leading fungal cause of mortality in immunocompromised patients, presents a serious worldwide challenge--particularly in the face of increasing antifungal resistance. Bringing together the world's leaders in the Aspergillus and aspergillosis fields to promote cross-disciplinary collaboration among clinicians, industry, and scientific experts, the "Advances Against Aspergillosis" conference was held January 26-28, 2012 in Istanbul,...